Cloudbreak Pharma Inc. (HKG:2592)

Cloudbreak Pharma Revenue

Cloudbreak Pharma had revenue of $44.00K USD in the half year ending June 30, 2026. This brings the company's total for the last twelve months to $269.00K, down -97.37% year-over-year. In the year 2025, Cloudbreak Pharma had annual revenue of $253.00K, down -97.52%. That makes Cloudbreak Pharma the 45,216th largest company in the world by revenue and 2,595th in Hong Kong.

• Revenue (ttm): $269.00K
• Revenue Growth: -97.37%
• P/S Ratio: 521.63
• Revenue / Employee: $4.41K
• Employees: 61
• Market Cap: 1.10B HKD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	253.00K	-9.96M	-97.52%
Dec 31, 2024	10.21M	9.33M	1,060.68%
Dec 31, 2023	880.00K	409.00K	86.84%
Dec 31, 2022	471.00K	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 1, 2026

Data Sources Report a data error